Abstract:Critically ill patients with systemic rheumatic diseases (SRDs) have a fair prognosis, while those with interstitial lung disease (ILD) have a poorer outcome. However, the prognosis of SRD patients with ILD admitted to the intensive care unit (ICU) remains unclear. We conducted a case–control study to investigate the outcomes of critically ill SRD-ILD patients. Consecutive SRD-ILD patients admitted to five ICUs from January 2007 to December 2017 were compared to SRD patients without ILD. Mortality rates were c… Show more
“…Rheumatic disease patients are usually considered immunosuppressed due to their underlying, malfunctioning immune system, which sometimes can be further exacerbated by the treatments they receive. A multicenter study in France found that the mortality rate of ILD patients with coexisting systemic rheumatic disease admitted to the intensive care unit was 40% compared to 16% of rheumatic disease patients without ILD [ 8 ]. With the high mortality rate in this patient population, any identifiable risk factors leading to respiratory failure and the need for intensive care unit-level care should be carefully addressed and managed in both inpatient and outpatient settings.…”
BackgroundSystemic sclerosis (SSc) patients are at high risk for respiratory failure due to the progression of their disease. Investigating factors predictive of impending respiratory failure in this patient population can be used to improve hospital outcomes. Here, we investigate risk factors associated with developing respiratory failure in patients hospitalized with a diagnosis of SSc in the United States using a large, multi-year, populationbased dataset.
MethodologyThis retrospective study was conducted on SSc hospitalizations from 2016 to 2019 with and without a principal diagnosis of respiratory failure from the United States National Inpatient Sample database. A multivariate logistic regression analysis was performed to calculate adjusted odds ratios (OR adj ) for respiratory failure.
ResultsThere were 3,930 SSc hospitalizations with a principal diagnosis of respiratory failure and 94,910 SSc hospitalizations without a diagnosis of respiratory failure. Among SSc hospitalizations, multivariable analysis showed that the following were associated with a principal diagnosis of respiratory failure: Charlson comorbidity index (OR adj = 1.05), heart failure (OR adj = 1.81), interstitial lung disease (ILD) (OR adj = 3.62), pneumonia (OR adj = 3.40), pulmonary hypertension (OR adj = 3.59), and smoking (OR adj = 1.42).
ConclusionsThis analysis represents the largest sample to date in assessing risk factors for respiratory failure among SSc inpatients. Charlson comorbidity index, heart failure, ILD, pulmonary hypertension, smoking, and pneumonia were associated with higher odds of inpatient respiratory failure. Patients with respiratory failure had higher in-hospital mortality compared to those without it. Outpatient optimization and inpatient recognition of these risk factors can lead to improved hospitalization outcomes for SSc patients.
“…Rheumatic disease patients are usually considered immunosuppressed due to their underlying, malfunctioning immune system, which sometimes can be further exacerbated by the treatments they receive. A multicenter study in France found that the mortality rate of ILD patients with coexisting systemic rheumatic disease admitted to the intensive care unit was 40% compared to 16% of rheumatic disease patients without ILD [ 8 ]. With the high mortality rate in this patient population, any identifiable risk factors leading to respiratory failure and the need for intensive care unit-level care should be carefully addressed and managed in both inpatient and outpatient settings.…”
BackgroundSystemic sclerosis (SSc) patients are at high risk for respiratory failure due to the progression of their disease. Investigating factors predictive of impending respiratory failure in this patient population can be used to improve hospital outcomes. Here, we investigate risk factors associated with developing respiratory failure in patients hospitalized with a diagnosis of SSc in the United States using a large, multi-year, populationbased dataset.
MethodologyThis retrospective study was conducted on SSc hospitalizations from 2016 to 2019 with and without a principal diagnosis of respiratory failure from the United States National Inpatient Sample database. A multivariate logistic regression analysis was performed to calculate adjusted odds ratios (OR adj ) for respiratory failure.
ResultsThere were 3,930 SSc hospitalizations with a principal diagnosis of respiratory failure and 94,910 SSc hospitalizations without a diagnosis of respiratory failure. Among SSc hospitalizations, multivariable analysis showed that the following were associated with a principal diagnosis of respiratory failure: Charlson comorbidity index (OR adj = 1.05), heart failure (OR adj = 1.81), interstitial lung disease (ILD) (OR adj = 3.62), pneumonia (OR adj = 3.40), pulmonary hypertension (OR adj = 3.59), and smoking (OR adj = 1.42).
ConclusionsThis analysis represents the largest sample to date in assessing risk factors for respiratory failure among SSc inpatients. Charlson comorbidity index, heart failure, ILD, pulmonary hypertension, smoking, and pneumonia were associated with higher odds of inpatient respiratory failure. Patients with respiratory failure had higher in-hospital mortality compared to those without it. Outpatient optimization and inpatient recognition of these risk factors can lead to improved hospitalization outcomes for SSc patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.